GSK.L - GSK plc
JPMorgan
GSK PLC CROI 2026 early data seems supportive of 6M dosing for VH184 and VH499, with regimen selected expected to be confirmed at Meet Management later this year
公司
GSK.L
日期
2026-02-26
分析师
Zain Ebrahim
页数
9 页
需要登录
请登录后购买研报或生成音频内容。